Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Xenome Ltd.
Questcor Pharmaceuticals, which develops treatments for autoimmune and inflammatory disorders, has named Michael Aldridge senior vice-president, corporate strategic development. Prior to joining California, US-based Questcor, Mr Aldridge served as chief executive officer, managing director and board member of Australian biopharma, Xenome. He will report to Questcor’s chief operating officer, Steve Cartt.
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical device sectors.
Asia life science-focused VC firms*
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
- Large Molecule
Drug Discovery Tools
- Natural Products
- Molecular Diversity